1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Avanafil
1.2.5 Vardenafil
1.3 Market by Application
1.3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Perspective (2017-2028)
2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Trends by Region
2.2.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Region (2017-2022)
2.2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2023-2028)
2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Dynamics
2.3.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Trends
2.3.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
2.3.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
2.3.4 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Revenue
3.1.1 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Revenue (2017-2022)
3.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Players (2017-2022)
3.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue
3.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio
3.4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2021
3.5 Phosphodiesterase Type 5 (PDE5) Inhibitor Key Players Head office and Area Served
3.6 Key Players Phosphodiesterase Type 5 (PDE5) Inhibitor Product Solution and Service
3.7 Date of Enter into Phosphodiesterase Type 5 (PDE5) Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Type
4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Type (2017-2022)
4.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2023-2028)
5 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Application
5.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Application (2017-2022)
5.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2017-2028)
6.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
6.2.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)
6.2.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028)
6.2.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2017-2028)
6.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
6.3.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)
6.3.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028)
6.3.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2017-2028)
6.4 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
6.4.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022)
6.4.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2017-2028)
7.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
7.2.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)
7.2.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028)
7.2.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2017-2028)
7.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
7.3.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)
7.3.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028)
7.3.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2017-2028)
7.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
7.4.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022)
7.4.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2017-2028)
8.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
8.2.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2017-2028)
8.3 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
8.3.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2017-2028)
8.4 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region
8.4.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2017-2028)
9.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
9.2.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)
9.2.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028)
9.2.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2017-2028)
9.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
9.3.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)
9.3.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028)
9.3.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2017-2028)
9.4 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
9.4.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022)
9.4.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2017-2028)
10.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
10.2.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2017-2028)
10.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
10.3.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2017-2028)
10.4 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
10.4.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.1.4 Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.1.5 Eli Lilly Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.2.4 Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.3.4 Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.3.5 Bayer Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.4.4 Novartis AG Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.4.5 Novartis AG Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.5.4 Merck Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.5.5 Merck Recent Developments
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Details
11.6.2 GlaxoSmithKline plc Business Overview
11.6.3 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.6.4 GlaxoSmithKline plc Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.6.5 GlaxoSmithKline plc Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.7.4 Roche Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.7.5 Roche Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.8.4 AstraZeneca Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.8.5 AstraZeneca Recent Developments
11.9 BaiYunShan General Factory
11.9.1 BaiYunShan General Factory Company Details
11.9.2 BaiYunShan General Factory Business Overview
11.9.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.9.4 BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.9.5 BaiYunShan General Factory Recent Developments
11.10 SK Chemicals
11.10.1 SK Chemicals Company Details
11.10.2 SK Chemicals Business Overview
11.10.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.10.4 SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.10.5 SK Chemicals Recent Developments
11.11 Teva Pharma
11.11.1 Teva Pharma Company Details
11.11.2 Teva Pharma Business Overview
11.11.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.11.4 Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.11.5 Teva Pharma Recent Developments
11.12 Dong-A ST
11.12.1 Dong-A ST Company Details
11.12.2 Dong-A ST Business Overview
11.12.3 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.12.4 Dong-A ST Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.12.5 Dong-A ST Recent Developments
11.13 Metuchen Pharma
11.13.1 Metuchen Pharma Company Details
11.13.2 Metuchen Pharma Business Overview
11.13.3 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.13.4 Metuchen Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.13.5 Metuchen Pharma Recent Developments
11.14 Seoul Pharma
11.14.1 Seoul Pharma Company Details
11.14.2 Seoul Pharma Business Overview
11.14.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.14.4 Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.14.5 Seoul Pharma Recent Developments
11.15 Vectura Group
11.15.1 Vectura Group Company Details
11.15.2 Vectura Group Business Overview
11.15.3 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.15.4 Vectura Group Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
11.15.5 Vectura Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Sildenafil
Table 3. Key Players of Tadalafil
Table 4. Key Players of Avanafil
Table 5. Key Players of Vardenafil
Table 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2017-2022)
Table 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2023-2028)
Table 12. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Trends
Table 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
Table 14. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
Table 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
Table 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Players (2017-2022)
Table 18. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2021)
Table 19. Ranking of Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Phosphodiesterase Type 5 (PDE5) Inhibitor Product Solution and Service
Table 23. Date of Enter into Phosphodiesterase Type 5 (PDE5) Inhibitor Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2017-2022)
Table 27. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2023-2028)
Table 29. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application (2017-2022)
Table 31. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application (2023-2028)
Table 33. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 66. Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 67. Eli Lilly Recent Developments
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 71. Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 72. Pfizer Recent Developments
Table 73. Bayer Company Details
Table 74. Bayer Business Overview
Table 75. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 76. Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 77. Bayer Recent Developments
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 81. Novartis AG Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 82. Novartis AG Recent Developments
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 86. Merck Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 87. Merck Recent Developments
Table 88. GlaxoSmithKline plc Company Details
Table 89. GlaxoSmithKline plc Business Overview
Table 90. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 91. GlaxoSmithKline plc Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 92. GlaxoSmithKline plc Recent Developments
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 96. Roche Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 97. Roche Recent Developments
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 101. AstraZeneca Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 102. AstraZeneca Recent Developments
Table 103. BaiYunShan General Factory Company Details
Table 104. BaiYunShan General Factory Business Overview
Table 105. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 106. BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 107. BaiYunShan General Factory Recent Developments
Table 108. SK Chemicals Company Details
Table 109. SK Chemicals Business Overview
Table 110. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 111. SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 112. SK Chemicals Recent Developments
Table 113. Teva Pharma Company Details
Table 114. Teva Pharma Business Overview
Table 115. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 116. Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 117. Teva Pharma Recent Developments
Table 118. Dong-A ST Company Details
Table 119. Dong-A ST Business Overview
Table 120. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 121. Dong-A ST Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 122. Dong-A ST Recent Developments
Table 123. Metuchen Pharma Company Details
Table 124. Metuchen Pharma Business Overview
Table 125. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 126. Metuchen Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 127. Metuchen Pharma Recent Developments
Table 128. Seoul Pharma Company Details
Table 129. Seoul Pharma Business Overview
Table 130. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 131. Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 132. Seoul Pharma Recent Developments
Table 133. Vectura Group Company Details
Table 134. Vectura Group Business Overview
Table 135. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 136. Vectura Group Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022) & (US$ Million)
Table 137. Vectura Group Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type: 2021 VS 2028
Figure 2. Sildenafil Features
Figure 3. Tadalafil Features
Figure 4. Avanafil Features
Figure 5. Vardenafil Features
Figure 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Other Case Studies
Figure 11. Phosphodiesterase Type 5 (PDE5) Inhibitor Report Years Considered
Figure 12. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region: 2021 VS 2028
Figure 15. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players in 2021
Figure 16. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2021
Figure 18. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2028)
Figure 20. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2028)
Figure 21. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Share by Country (2017-2028)
Figure 22. United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2028)
Figure 26. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2028)
Figure 27. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Share by Country (2017-2028)
Figure 28. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Share by Region (2017-2028)
Figure 38. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Share by Country (2017-2028)
Figure 48. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Share by Country (2017-2028)
Figure 54. Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Eli Lilly Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 59. Bayer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 60. Novartis AG Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 61. Merck Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 62. GlaxoSmithKline plc Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 63. Roche Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 64. AstraZeneca Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 65. BaiYunShan General Factory Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 66. SK Chemicals Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 67. Teva Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 68. Dong-A ST Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 69. Metuchen Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 70. Seoul Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 71. Vectura Group Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
